Royalty Pharma company profile
Company profile
Royalty Pharma has 100 employees and is headquartered in New York, United States.
Royalty Pharma plc is known by its royalty portfolio on medicines, which covers about 35 marketed therapies and around 20 development-stage product candidates. The company buys biopharmaceutical royalties and funds innovation in the biopharmaceutical industry, with a portfolio spanning rare disease, oncology, neuroscience, infectious disease, hematology and diabetes. It also has a research and development funding collaboration to advance JNJ-4804, an investigational medicine for autoimmune diseases.
In the fiscal year ended December 2025, the company reported revenue of $2.4 billion, up 5.1% from the previous year, and net income of $770.9 million. Royalty Pharma was founded in 1996 and is headquartered in New York, New York, and it employs 100 people.
Company facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Headquarters
- 110 East 59th Street, 10022, New York
- Employees
- 100
- Chief executive
- Pablo Legorreta
- Founded
- 1996
- Fiscal year
- January - December
- Listing
- RPRX · NASDAQ
- Currency
- USD
- ISIN
- GB00BMVP7Y09
- Website
- royaltypharma.com
Royalty Pharma and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Royalty PharmaRPRX | United States | $39.4B | 100 | 64.4% | 45.4 |
| Revolution MedicinesRVMD | United States | $37.27B | 883 | -853.0% | — |
| BeOne MedicinesONC | United States | $46.98B | 12,000 | 17.8% | 52.7 |
| Roivant SciencesROIV | United States | $28.64B | 721 | -3,226.3% | — |
| InsmedINSM | United States | $26.96B | 1,664 | -41.7% | — |
| argenxARGX | United States | $59.8B | 1,863 | 31.9% | 32.9 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
